000 01424 a2200409 4500
005 20250512053943.0
264 0 _c19870304
008 198703s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1986.258
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDhokia, B
245 0 0 _aA new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.
_h[electronic resource]
260 _bBritish journal of cancer
_cDec 1986
300 _a891-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aAntigens, Neoplasm
_xanalysis
650 0 4 _aAntigens, Tumor-Associated, Carbohydrate
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aMembrane Proteins
_xanalysis
650 0 4 _aMucin-1
650 0 4 _aOvarian Neoplasms
_xdiagnosis
650 0 4 _aTime Factors
700 1 _aCanney, P A
700 1 _aPectasides, D
700 1 _aMunro, A J
700 1 _aMoore, M
700 1 _aWilkinson, P M
700 1 _aSelf, C
700 1 _aEpenetos, A A
773 0 _tBritish journal of cancer
_gvol. 54
_gno. 6
_gp. 891-5
856 4 0 _uhttps://doi.org/10.1038/bjc.1986.258
_zAvailable from publisher's website
999 _c3473515
_d3473515